GPR12 Activators are a class of compounds that interact with or influence the signaling pathways of the G protein-coupled receptor GPR12. These activators can enhance the receptor's activity by engaging with the complex network of intracellular signaling cascades that GPR12 is part of. Sphingosine-1-phosphate (S1P), for instance, is a lipid signaling molecule that binds to GPR12, leading to the activation of downstream signaling pathways involving calcium mobilization and inhibition of adenylyl cyclase. This interaction enhances GPR12's ability to respond to external stimuli and propagate cellular responses. Similarly, lysophosphatidic acid (LPA) stimulates GPR12 by activating G proteins, which in turn initiate a series of intracellular events such as the activation of phospholipase C. This leads to the generation of diacylglycerol and inositol trisphosphate, second messengers that further modulate cellular functions associated with GPR12.
Other compounds like anandamide and 2-Arachidonoylglycerol (2-AG) are part of the endocannabinoid system and act on G protein-coupled receptors like GPR12 to trigger signaling mechanisms that enhance the receptor's activity. Anandamide's binding to GPR12 can facilitate the activation of the PI3K/AKT pathway, which is crucial for several cellular processes. On the other hand, 2-AG can inhibit adenylyl cyclase and activate MAPK, which are key pathways in GPR12 signaling. Adenosine and uridine diphosphate (UDP) are purines that interact with their respective G protein-coupled receptors, and through signaling cross-talk, they can enhance the function of GPR12. Additionally, compounds like FTY720 and VPC 23019 modulate sphingosine 1-phosphate receptors, affecting GPR12 indirectly by influencing the sphingosine-related pathways, which are integral to GPR12's role in cellular signaling. Cannabidiol (CBD) and CP-55,940 modulate the endocannabinoid system, which shares signaling pathways with GPR12, and their interactions can lead to an enhanced functional activity of GPR12. Lastly, capsaicin, by binding to the vanilloid receptor, influences GPR12 activity through downstream effectors such as calcium ions and protein kinase C (PKC), highlighting the diverse yet specific ways in which these compounds can enhance the functionality of GPR12.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is an analog of cyclic AMP (cAMP) that increases intracellular cAMP levels, leading to the activation of cAMP-dependent pathways, including protein kinase A (PKA) and other downstream signaling events. These pathways may indirectly influence GPCR signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can modulate various intracellular signaling pathways. PKC activation may indirectly influence GPCR signaling. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $343.00 $1642.00 | 20 | |
Calphostin C is an inhibitor of PKC, potentially affecting downstream signaling pathways that intersect with GPCR signaling. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), increasing cAMP levels and activating cAMP-dependent pathways, indirectly impacting GPCR signaling. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
8-Br-cGMP is an analog of cyclic GMP (cGMP) that can influence cellular processes regulated by cGMP, potentially intersecting with GPCR-mediated pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of phosphoinositide 3-kinase (PI3K), a key player in the PI3K/Akt signaling pathway, which may intersect with GPCR signaling pathways. | ||||||